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Abstract
Background:  An  outbreak  of  Legionella  pneumophila  serogroup  1,  with  403  cases  was  identiﬁed
on the  7th  November  2014  in  Vila  Franca  de  Xira,  Portugal.  Outbreak  source  was  the  wet  cooling
system of  a  local  factory.  Hospital  Pulido  Valente  was  one  of  the  hospitals  receiving  patients
with Legionnaires’  disease  (LD).
Methods:  We  describe  the  clinical  ﬁndings  and  diagnostic  methods  used  among  the  43  conﬁrmed
or probable  cases  admitted  to  our  department.
Results:  60.5%  were  male,  mean  age  was  56.1  ±  13.5  years  and  tobacco  smoking  was  the  most
frequent risk  factor  (76.7%).  All  patients  had  fever,  62.8%  ≥39.5 ◦C,  72.1%  had  chills  and  myal-
gia/arthralgia  and  62.8%  had  dry  cough.  Extra  pulmonary  symptoms  were  frequent:  confusion
and headache  occurred  in  34.9%  and  gastrointestinal  symptoms  in  20.9%.
High C-Reactive  Protein  (55.8%  ≥30  mg/dL)  and  hyponatremia  (62.8%)  were  the  laboratorial
nly  found.  Hypoxemia  occurred  in  55.8%  and  hypocapnia  in  93%.
was  positive  in  83.7%  of  the  cases.
speciﬁc,  a  combination  of  risk  factors,  symptoms  and  laboratory
estive  of  LD,  even  in  an  outbreak.  This  should  prompt  diagnosisabnormalities  most  commo
Urinary Antigen  Test  (UAT)  
Conclusions:  Although  not  
ﬁndings  can  be  highly  sugg∗ Corresponding authors.
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conﬁrmation.  Routine  use  of  UAT  in  less  severe  cases  of  community  acquired  pneumonia  might
contribute  to  earlier  diagnosis.
©  2017  Sociedade  Portuguesa  de  Pneumologia.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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egionella  species  (spp.)  is  a  relatively  common  agent  of
ommunity  and  hospital  acquired  pneumonia.1 It  was  ﬁrst
dentiﬁed  as  the  pathogen  responsible  for  a  pneumonia  out-
reak  during  an  American  Legion  Convention  in  July  1976  in
hiladelphia.  Hence  its  name,  Legionnaires’  disease  (LD).2
t  occurs  in  outbreaks  or  sporadically.3,4
Bacteria  of  the  genus  Legionella  include  56  species  and
ore  than  70  serogroups.  The  most  common  specie  is
egionella  pneumophila, serogroup  1  which  accounts  for  90%
f  cases  of  LD  and  was  the  agent  responsible  for  the  1976
utbreak.5,6 Legionella  pneumophila  serogroup  1  is  further
ivided  into  multiple  subtypes.
Although  L.  pneumophila  serogroup  1  accounts  for  90%  of
ases  in  Europe  and  America,  this  incidence  could  be  lower
n  some  countries,  such  as  Australia  and  New  Zealand,  where
egionella  longbeacheae  accounts  for  30%  of  cases.7
The  incubation  period  is  usually  between  2  and  10  days.4,8
n  about  10%  of  cases  the  incubation  period  can  be  longer,
asting  more  than  10  days  and  up  to  19  days.9,10
Diagnosis  is  based  on  clinical  suspicion  together  with
aboratory  conﬁrmation.  Legionella  culture  of  a  respira-
ory  specimen  and  urinary  antigen  testing  are  the  most
idely  used.4,8 Although  the  clinical  manifestations  are
on-speciﬁc,  a  combination  of  risk  factors,  symptoms  and
aboratorial  ﬁndings  can  be  suggestive  of  LD.11--13 It  usually
resents  as  severe  pneumonia  with  a  particular  pattern  of
ultisystem  dysfunction.  As  with  other  pneumonias  caused
y  ‘‘atypical  pathogens’’,  respiratory  symptoms  may  not
e  the  most  prominent.  Neurological  and  gastrointesti-
al  involvement,  myalgia  and  arthralgia,  hepatic  cytolysis,
yponatremia,  hypophosphatemia  and  renal  failure  are  fre-
uently  present.4,11--15
An  outbreak  of  L.  pneumophila  serogroup  1  with  403
ases,  377  conﬁrmed  and  26  probable  cases,  was  identiﬁed
n  the  7th  November  2014  in  Vila  Franca  de  Xira,  located  30
m  north  of  Lisbon,  Portugal.16 The  outbreak  started  on  the
2th  October,  with  peak  incidence  on  the  6th  November.
ontrol  of  outbreak  was  achieved  on  the  21st  November,
ith  its  end  declared  on  the  2nd  December  (date  of  start
f  symptoms  of  the  last  case).  Of  the  total  of  403  cases,
here  were  14  reported  deaths,  leading  to  a  3.5%  overall
ase  fatality  rate.  Epidemiological  investigation  identiﬁed
he  most  probable  outbreak  source  as  the  wet  cooling  sys-
em  of  a  local  factory.  These  facilities  were  shut  down  on
he  9th  November.17 Interestingly  it  was  during  this  outbreak
hat  the  very  ﬁrst  probable  person  to  person  transmission  of
D  has  been  described.18
During  the  outbreak  several  hospitals  were  appointed
o  receive  patients  from  Vila  Franca  de  Xira,  and  Hospital
ulido  Valente  --  Centro  Hospitalar  Lisboa  Norte  was  one  of
s
a
ﬂhem.  The  authors  describe  the  clinical  ﬁndings  and  diag-
ostic  methods  used  among  the  43  conﬁrmed  or  probable
ases  of  LD  admitted  in  our  trust.
aterials and methods
orty-three  patients  with  conﬁrmed  or  probable  LD  were
dmitted  to  the  Chest  Department  at  Hospital  Pulido  Valente
etween  the  7th  and  15th  November  2014.  Case  deﬁnition
as  based  on  established  criteria  by  the  Legionnaires’  Dis-
ase  Surveillance  European  Union  (EU)  which  was  adopted
y  the  Portuguese  Directorate  General  of  Health  (DGH)
Table  1).8,19
A  questionnaire  was  applied  to  all  patients  transferred
rom  the  at  risk  areas  with  a  clinical  suspicion  of  LD.  Data
egarding  demographics,  risk  factors,  clinical  presentation,
aboratorial  and  radiological  features  and  microbiological
esting  was  collected  and  analyzed.
A  smoker  was  deﬁned  as  a  person  who,  at  the  time  of  the
urvey,  had  smoked  at  least  100  cigarettes  in  his/her  lifetime
nd  currently  smokes  cigarettes  every  day  or  occasionally.
n  ex-smoker  was  a  person  who  used  to  be  a  smoker  but  had
ot  smoked  at  all  for  at  least  6  months  at  the  time  of  the
urvey.20
Statistical  analysis  was  performed  aimed  at  a  descriptive
nalysis  of  the  LD  cases.  More  speciﬁcally  for  categorical
ariables  absolute  and  relative  frequencies  were  calculated,
or  numerical  variables  means,  medians  and  standard  devi-
tions  (sd)  were  used  to  characterize  their  distribution.  All
ata  analysis  was  performed  using  Microsoft  Excel  (2007).
esults
f  the  43  patients,  38  (88.4%)  were  conﬁrmed  cases  and  5
11.6%)  were  probable  cases.  The  total  of  43  cases  repre-
ents  around  10.7%  of  the  total  403  cases  identiﬁed  during
he  outbreak.
All  patients  received  levoﬂoxacin  and  in  our  series  there
ere  no  deaths.  Seven  patients  were  admitted  to  the  Inten-
ive  Care  Unit  (ICU)  and  11  to  the  Intermediate  Care  Unit
ITCU).  Invasive  Mechanical  Ventilation  (IMV)  was  needed
n  two  patients  and  Non  Invasive  Ventilation  (NIV)  in  eight
atients.  All  patients  were  admitted  after  the  outbreak  had
een  declared.  The  majority  was  ﬁrst  seen  in  the  Emergency
oom  (ER)  closest  to  the  outbreak  source  (Hospital  de  Vila
ranca  de  Xira).Fever  was  present  for  a  mean  of  4.0  days  before  patients
ought  medical  assistance.  Every  patient  with  suspected  LD
nd  epidemiological  link  was  medicated  with  high  dose  levo-
oxacin  (750  mg)  before  being  transferred  to  our  hospital.
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Table  1  Outbreak  case  deﬁnition  adopted  by  Portuguese  Directorate-General  of  Health  based  on  the  Legionnaires’  Disease
Surveillance European  Union  (EU)  case  deﬁnition  criteria.
Case  deﬁnition  Probable  case:  Any  person  meeting  the  clinical  and  epidemiological  criteria  and  at
least one  laboratory  criterion  for  a  probable  case
Conﬁrmed  case:  Any  person  meeting  the  clinical  and  epidemiological  criteria  and
at least  one  laboratory  criterion  for  a  conﬁrmed  case
Clinical criteria  Any  person  with  pneumonia
Epidemiological  criteria  Symptom  onset  occurring  between  12/10/2014  and  02/12/2014  and  history  of
living, working  or  visiting  at  risk  areas7 during  the  period  of  2  to  19  days  before
symptom  onset.
Laboratory  criteria  for  conﬁrmed  case At  least  one  of  the  three  following  laboratory  ﬁndings:  a)  isolation  of  Legionella
spp. from  respiratory  secretions  or  any  normally  sterile  site;  b)  detection  of
Legionella  pneumophila  antigen  in  urine;  c)  signiﬁcant  rise  in  speciﬁc  antibody
level to  Legionella  pneumophila  serogroup  1  in  paired  serum  samples.
Laboratory criteria  for  probable  case  At  least  one  of  the  following  four  laboratory  ﬁndings:  a)  detection  of  Legionella
pneumophila  antigen  in  respiratory  secretions  or  lung  tissue  e.g.  by  DFA  staining
using monoclonal-antibody  derived  reagents;  b)  detection  of  Legionella  spp.
nucleic acid  in  respiratory  secretions,  lung  tissue  or  any  normally  sterile  site;  c)
signiﬁcant  rise  in  speciﬁc  antibody  level  to  Legionella  pneumophila  other  than
serogroup  1  or  other  Legionella  spp.  in  paired  serum  samples;  d)  single  high  level
of speciﬁc  antibody  to
Table  2  Demographics  and  host  risk  factors  of  the  43  con-
ﬁrmed/probable  patients.
Characteristics  Conﬁrmed/probable
cases
N  (%)
Gender
Male  26  (60.5)
Female  17  (39.5)
Age  (mean  ±  SD)  56.1  ±  13.5
Age median  59
Active  smoker  or  ex-smoker  33  (76.7)
Chronic  respiratory  disease  9  (20.9)
COPD  6  (14.0)
Asthma  2  (4.7)
OSAS  2  (4.7)
Diabetes  mellitus  7  (16.3)
Active  cancer/Malignancy  1  (2.3)
Chronic  therapy  with  systemic
steroids  or  other
immunosuppressive  treatment
0
≥1  risk  factor  10  (23.3)
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bSD: standard deviation; COPD: Chronic Obstructive Pulmonary
Disease; OSAS: Obstructive Sleep Apnea Syndrome.
Patients  were  maintained  on  monotherapy  with  high  dose
levoﬂoxacin  for  a  mean  period  of  8.9  days.
Demographic  characteristics  and  host  risk  factors
Demographic  characteristics  and  host  risk  factors  are  pre-
sented  in  Table  2.  Twenty-six  patients  were  male  and  17
were  female.  Mean  age  was  56.1  and  median  age  was  59
years  old.  The  youngest  and  oldest  patients  were  22  and  85
years  old,  respectively.  Around  three  quarters  were  of  active
age:  74.4%  were  within  35--65  years.
i
N
r
o Legionella  pneumophila  serogroup  1  in  serum.
The  main  risk  factors  identiﬁed  were  tobacco  smoking
active  smokers  or  ex-smokers)  accounting  for  76.7%  of
atients,  chronic  respiratory  disease  (20.9%)  and  diabetes
ellitus  (16.3%).  More  than  1  risk  factor  was  present  in  23.3%
f  patients.  One  patient  had  gastric  cancer  and  none  were
nder  steroids  or  other  immunosuppressive  treatment.  HIV
erology  was  performed  in  35  patients  (81.4%).  HIV-2  sero-
ogy  was  positive  in  one  patient  with  a  CD4+  lymphocyte  cell
ount  of  454  cells/L. Although  not  established  as  a  risk  fac-
or,  56.8%  had  cardiovascular  disease,  mainly  hypertension.
linical,  laboratorial  and  radiological  presentation
linical  features,  radiological  and  laboratory  results  are  pre-
ented  in  Table  3. All  patients  had  fever  (T  ≥  38 ◦C),  in  79.1%
f  patients  ≥39 ◦C,  in  62.8%  ≥39.5 ◦C  and  maximum  temper-
ture  was  40.5 ◦C.
Chills,  myalgia  and  arthralgia  were  present  in  72.1%  of
he  patients.  Dry  cough  was  the  most  frequent  respira-
ory  symptom  (62.8%)  and  productive  cough  was  the  least
16.3%).  Both  dyspnea  and  chest  pain  were  present  in  less
han  40%  of  the  cases.  Extrapulmonary  symptoms  were  fre-
uent,  with  34.9%  of  patients  presenting  with  confusion
nd/or  headache.  Gastrointestinal  symptoms,  such  as  nau-
ea,  vomiting  and  diarrhea  were  reported  in  20.9%  of  the
atients.
Fifty-six  percent  of  the  patients  had  C-Reactive  Protein
CRP)  above  30  mg/dL  (mean  value  of  33.8,  minimum  14.3
nd  maximum  66.9  mg/dL).  Leukocytosis  was  found  in  48.8%
f  the  patients  (mean  value  of  12  210  ×  109 cells/L).  Normal
latelet  count  (150--450  ×  109/L)  was  found  in  the  major-
ty  of  patients  (n  =  36,  83.7%)  and  22.5%  had  platelet  count
elow  171  ×  109/L.  The  most  common  laboratory  abnormal-
ties  were:  hyponatremia  (Na  <135  mmol/L)  in  62.8%,  with
a  <130  in  20.9%,  hepatic  cytolysis  (AST  >34  U/L)  in  54.8%,
aised  creatinine  in  51.2%,  and  hypophosphatemia  in  42.9%
f  the  cases.
120  
Table  3  Clinical  and  laboratory  features.
Characteristics  Conﬁrmed/probable
cases
N  (%)
Clinical  features  (all  items  were  collected  separately)
General  symptoms  and  signs
Fever  T  ≥38 ◦C  43  (100.0)
Fever  T  ≥39 ◦C  34  (79.1)
Fever  T  ≥39.5 ◦C  27  (62.8)
Chills 31  (72.1)
Myalgia/arthralgia  31  (72.1)
Lethargy/tiredness  19  (44.2)
Respiratory  symptoms
Dry  cough  27  (62.8)
Productive  cough  7  (16.3)
Dyspnea  17  (39.5)
Chest  pain  14  (32.6)
Neurological  symptoms
Headache  15  (34.9)
Mental  confusion  15  (34.9)
Gastrointestinal  symptoms
Nausea  9  (20.9)
Vomiting  9  (20.9)
Diarrhea  9  (20.9)
Laboratory  results
CRP  ≥18  mg/dL  39  (90.7)
CRP ≥25  mg/dL 31  (72.1)
CRP ≥30  mg/dL  24  (55.8)
Leukocytosis  (>12  ×  109 cells/L) 21  (48.8)
Platelets  <171  ×  109 cells/L  11  (25.5)
Na <135  mEq/L 27  (62.8)
P <2.4  mEq/L 9  (42.9)
performed
in  n  =  21
AST >34  U/L  23  (54.8)
performed
in n  =  42
Creatinine  >1.3  mg/dL  22  (51.2)
CK >294  U/L  10  (28.6)
performed
in n  =  35
Arterial  Blood  Gas  resultsa
PO2 <60  mmHg  13  (30.2)
PO2 <70  mmHg  24  (55.8)
PCO2 <45  mmHg  43(100.0)
PCO2 <35  mmHg  40  (93)
a ABG performed at admission with FIO 21%.
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older  population  with  70%  of  patients  being  older  than  5021
and  in  the  review  by  Sopena  52.2%  where  older  than  60.3 In2
All  patients  had  arterial  blood  gas  samples  drawn  on  room
ir  (FiO2 21%)  on  admission.  Hypoxemia  (PO2 <70  mmHg)  was
ound  in  55.8%  of  the  patients  and  93%  had  hypocapnia  (PCO2
35  mmHg).
All  patients  had  a  chest  X-ray  on  admission  document-
ng  evidence  of  pneumonia.  X-ray  was  repeated  within  72  h,
espite  clinical  evolution.  Fourteen  percent  (n  =  6)  had  bilat-
ral  involvement  at  admission  and  half  of  these  patients
ere  treated  in  the  intermediate/intensive  Care  Units.
wenty-three  percent  (n  =  10)  had  worsening  radiological
t
wA.  Dias  et  al.
eatures  within  the  ﬁrst  72  h  of  hospitalization  and  half  of
hem  were  admitted  to  the  ICU.
icrobiological  testing
ll  patients  had  Urinary  Antigen  Testing  for  L.  pneumophila
erogroup  1 (Alere  BinaxNOW
®
Legionella  Urinary  Antigen
ard).  This  was  positive  in  n  =  36  (83.7%).  In  the  36  conﬁrmed
ases  by  UAT,  serology  was  not  performed  and  respiratory
ecretions  were  collected  in  15  patients,  and  culture  was
ositive  in  6.  Among  the  7  patients  with  negative  UAT,
here  were  two  additional  conﬁrmed  cases:  one  by  isola-
ion  of  Legionella  spp.  from  respiratory  secretions  and  one
y  analysis  of  signiﬁcant  serological  titer  elevation  in  paired
amples.  The  5  remaining  cases  were  probable  cases,  with
 single  high  level  of  speciﬁc  antibody  to  L.  pneumophila
erogroup  1 in  serum.
Blood  cultures  were  performed  in  all  patients  and  neg-
tive  in  all  for  any  pathogen,  speciﬁcally  for  Streptococcus
neumoniae.
Fig.  1  shows  the  standard  demographic  and  clinical  ﬁnd-
ngs  of  LD  in  our  studied  population  (our  ‘‘typical’’  patient).
iscussion
o  date,  the  largest  outbreak  of  LD  happened  in  Murcia,
pain  in  2001  with  449  conﬁrmed  cases.  The  Vila  Franca  de
ira  outbreak,  with  403  cases,  was  the  second  largest.16,17,21
The  outbreak  started  on  the  12th  October  2014  but  was
nly  declared,  26  days  later,  on  the  7th  November.8 Our
tudy  was  not  able  to  identify  the  reason  for  the  delay
n  declaring  the  outbreak,  but  we  hypothesize  that  this
ould  be  related  to  the  high  population  density  of  the
rea  affected  by  the  outbreak  and  the  number  of  different
ealth  care  facilities  involved.  Other  reasons  include  the
act  that  there  are  no  national  recommendations  in  Portu-
al  for  requesting  UAT  in  patients  with  Community  Acquired
neumonia.  As  for  this,  UAT  is  performed  in  severe  cases,
hose  admitted  to  ICU  or  during  an  outbreak,  as  recom-
ended  by  the  Portuguese  Respiratory  Society  guidelines
or  the  management  of  community--acquired  pneumonia  in
mmunocompetent  adults.22
As  the  outbreak  had  already  been  declared  when  the
atients  were  admitted  to  our  hospital,  UAT  was  performed
n  all  of  them,  regardless  of  disease  severity.
Although  our  population  of  patients  amounted  to  43  cases
10.7%  of  the  total  number  of  cases)  we  believe  it  is  repre-
entative  of  the  clinical  manifestations  of  LD,  which  are  in
ine  with  the  literature.  The  distribution  of  gender  and  age
eﬂect  the  demographic  characteristics  of  the  population
xposed  to  contamination.  This  is  mainly  a  working  popula-
ion  in  an  industrial  area,  many  of  whom  commute  to  work
n  the  capital.
All  series  report  a  greater  incidence  in  males11,14,23,24
lthough  the  age  distribution  in  our  series  was  younger  with
4.4%  of  cases  being  between  35  and  65  years  of  age  with
 mean  age  of  56.1  years.  The  Murcia  outbreak  showed  anhe  analysis  of  CAPNETZ  by  von  Baum  et  al.,  the  mean  age
as  63.25
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Patient ID:  male , 56 years old
Findings in % patients
T ≥ 38ºC
CRP ≥ 18mg/dL
PaCO2 < 35 mmHg
Cigarrete smoking
T ≥ 39º C
Chills
Myalgia/arthralgya
CRP ≥ 25 mg/dL
Positive UAT
Male gender
T ≥ 39.5ºC
Dry cough
Na < 135 mEq/L
≥ 60%
≥
≥
 90%
70%
Mental confusion (34.9%)
Headache (34.9%)
Fever ≥ 39.5ºC (62.8%)
Dry cough (62.8%)
Chills (72.1%)
Myalgia/arthralgia (72.1%)
CRP ≥ 25 mg/dL (72.1%)
Na < 135 mEQ/L (62.8%)
P < 2.4 mEQ/L (42.9%)
PCO2 < 35 mmHg (93%)
UAT + (83.7%)
Nausea,
vomiting,
diarrhea
(20.9%)
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Our  series  showed  that  the  most  prevalent  risk  factor
was  smoking  history  (current  or  past)  which  was  present  in
76.7%  of  patients.  Again  this  was  in  accordance  with  previous
series.3,25--27 Chronic  respiratory  diseases,  frequently  quoted
as  a  risk  factor,  9.7%  in  the  Sopena  series3 and  36%  in  von
Baum’s,25 was  identiﬁed  in  20.9%  of  our  population  In  our
series,  diabetes  mellitus  was  found  in  16.3%  of  patients.  Sim-
ilar  values  were  also  found  in  other  studies.3,13,26 However,
diabetes  mellitus  prevalence  in  the  Portuguese  population
aged  20--79  years  old  was  13.1%  in  2014.28 Also,  in  an  out-
break  of  LD  in  2000  in  Melbourne,  Australia,  a  case--control
study  did  not  ﬁnd  signiﬁcant  difference  in  risk  factors
between  patients  and  the  general  population,  with  the
exception  of  smoking.26
The  low  incidence  of  immunosuppressive  therapy  and/or
active  cancer  as  well  as  a  high  incidence  of  high  blood
pressure  in  the  population  reﬂect  the  demographic  char-
acteristics  and  is  likely  to  have  no  other  signiﬁcance.  It  is
unknown  what  the  HIV  prevalence  was  in  the  population
exposed  to  LD  outbreak,  however  the  patient  diagnosed
with  HIV-2  had  a  CD4  lymphocyte  cell  count  ≥350  cells/L.
Thus,  in  this  patient  HIV  infection  probably  did  not  con-
tribute  signiﬁcantly  as  a  risk  factor  for  LD,  which  remains
in  accordance  to  other  published  data.29
All  patients  had  fever,  ≥39 ◦C  in  nearly  80%  of  patients.
According  to  some  authors  this  alone  should  raise  the  sus-
picion  of  LD.15 As  expected,  respiratory  symptoms  were  not
predominant,  with  the  most  common  being  a  dry  cough  in
two  thirds  of  patients.15,30 Chills,  myalgia  and  arthralgia
were  predominant  in  our  series  (72.1%  of  cases)  and  is  doc-
umented  in  the  literature,15 however  the  latter  was  more
prevalent  when  compared  with  other  studies  that  quoted  a
prevalence  around  40%.15,30,31
a
s
Cical’’  patient.
Around  one  third  of  patients  had  neurological  complaints
headache  and/or  confusion)  and  20.9%  had  gastrointestinal
ymptoms,  mainly  diarrhea,  nausea  and  vomit.  These  values
re  similar  to  values  from  other  studies.15,23,30,32
Regarding  laboratory  ﬁndings  our  series  conﬁrms  very
igh  CRP  (mean  value:  33.8  mg/dL)  which  is  in  line  with
ther  series.13,33,34 Other  ﬁndings  already  described  in  the
iterature  include  hyponatraemia,13,30,35 hypophosphatemia,
aised  liver  enzymes  and  decreased  renal  function.15
lthough  CRP  was  markedly  high,  51%  of  the  patients  did  not
ave  raised  white  cell  count  or  neutrophilia,  which  again,
as  found  by  Sopena,3 Viasus30 and  Benito.32
In  25.5%  of  patients,  there  was  a  platelet  count  below
71  ×  109/L,  which  is  one  of  the  independent  predic-
or  variables  in  the  LD  score  proposed  by  Fiumefreddo
t  al.13
The  majority  of  patients  had  hypoxemia  (PO2 <70  mmHg),
ith  30.2%  having  PO2 <60  mmHg,  ﬁndings  that  are  similar  to
hose  found  by  Benito  et  al.,32 with  33%  and  Sopena  et  al.3
ith  31%.  It  is  unusual  to  ﬁnd  any  references  in  the  literature
o  PCO2 values  but  our  series  showed  that  PCO2 was  below
5  mmHg  in  93%  of  patients  and  this  hypocapnia  could  be  an
ndirect  marker  of  tachypnea.
Twenty-three  percent  of  cases  showed  worsening  of
adiological  ﬁndings  during  the  ﬁrst  72  h  of  admission.  This
as  been  described  in  other  studies36 suggesting  that  it  could
e  a more  particular  feature  of  LD  than  of  other  pneumo-
ias.  Half  of  these  patients  needed  admission  to  the  ICU  and
wo  required  IMV.Despite  being  highly  sensitive,  a  sensitivity  close  to  100%
ccording  to  Rihs  et  al.,37 the  UAT  for  L.  pneumophila
erogroup  1  (Alere  BinaxNOW
®
Legionella  Urinary  Antigen
ard),  which  was  applied  to  all  our  patients,  was  positive
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122  
n  83.7%.  An  even  smaller  number  was  found  in  the  Murcia
utbreak,  with  only  47.7%  of  the  cases  having  positive  UAT.
he  variability  of  sensitivity  could  reﬂect  disease  severity;
ith  higher  positive  rates  in  more  severe  disease.38 Our  data
lso  questions  the  indication  for  blood  cultures  during  LD
utbreaks.
Finally,  in  our  series  all  patients  were  treated  with  high
ose  levoﬂoxacin  in  monotherapy  and  there  were  no  deaths.
owever,  alertness  was  high  because  the  outbreak  had
lready  been  declared  when  our  patients  were  admitted
after  7th  November  2014).  To  evaluate  case  fatality  rate,
he  DGH  included  deaths  occurring  since  1st  October  2014
nd  a  few  patients  died  within  this  period.8
In  our  series  early  diagnosis,  prompt  treatment  and  opti-
ization  of  process  of  care  may  have  contributed  to  these
esults.
onclusions
lthough  clinical  presentation  is  not  speciﬁc,  our  study
hows  that  even  during  an  outbreak,  the  combination  of
isk  factors,  symptoms  and  laboratory  ﬁndings  can  be  highly
uggestive  of  LD.  This  can  and  should  prompt  further  inves-
igations  in  order  to  conﬁrm  LD,  particularly  in  patients
ith  less  severe  presentation  or  with  negative  UAT.  Also,
idespread  use  of  UAT,  not  limited  to  the  severe  cases  of
ommunity  acquired  pneumonia  with  ICU  admission  crite-
ia,  might  contribute  to  earlier  diagnosis,  both  in  sporadic
ases  and  in  outbreaks  of  LD.
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